Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

PainReform Ltd. Ordinary Shares (PRFX)

https://www.painreform.com

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/01/2020

Market Cap

1,121,976

Shares Outstanding

1,560,000

Weighted SO

2,026,243

Total Employees

N/A

Upcoming Earnings

08/21/2024

Similar Tickers

QLI --.--%

RGC --.--%

PROC --.--%

JUPW --.--%

UPC --.--%

VRTHF --.--%

EGRX --.--%

SGBI --.--%

FLGC --.--%

Beta

0.6080

Last Div

0.0000

Range

0.29-5.336

Chg

0.0121

Avg Vol

216341

Mkt Cap

1121976

Exch

NASDAQ

Country

IL

Phone

972 3 717 7050

DCF Diff

-4.0337

DCF

6.0737

Div Yield

0.0000

P/S

999999.9999

EV Multiple

0.2187

P/FV

0.3547

Div Yield %

0.0000

P/E

-0.0523

PEG

-0.0039

Payout

0.0000

Current Ratio

1.6124

Quick Ratio

1.6124

Cash Ratio

1.3323

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

4487.3529

CCC

-4487.3529

Gross Margin

-999999.9999

Op Margin

-999999.9999

Pretax Margin

-999999.9999

Net Margin

-999999.9999

Eff Tax Rate

0.1158

ROA

-2.3360

ROE

-2.0310

ROCE

-6.0175

NI/EBT

1.0006

EBT/EBIT

0.9844

EBIT/Rev

-999999.9999

Debt Ratio

0.0134

D/E

0.0390

LT Debt/Cap

0.0081

Total Debt/Cap

0.0375

Int Coverage

-749.0000

CF/Debt

-115.9621

Equity Multi

2.9053

Rec Turnover

0.0000

Pay Turnover

0.0813

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-4.1206

FCF/Share

-4.1284

Cash/Share

2.1389

OCF/Sales

-999999.9999

FCF/OCF

1.0019

CF Coverage

-115.9621

ST Coverage

-146.4784

CapEx Coverage

-523.9119

Div&CapEx Cov

-523.9119

P/BV

0.3547

P/B

0.3547

P/S

999999.9999

P/E

-0.0523

P/FCF

-0.1341

P/OCF

-0.0785

P/CF

-0.0785

PEG

-0.0039

P/S

999999.9999

EV Multiple

0.2187

P/FV

0.3547

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 22, 08:30 PainReform to Present at the Microcap Conference in Atlantic City GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds GlobeNewswire Inc. Dec 26, 18:00 PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds

Revenue Product Segmentation